BIMAGRUMAB Overview
Upcoming Projects (BIMAGRUMAB)
-
Don’t see a project related to the keyword you care about? Create your own!
Executed Projects (BIMAGRUMAB)
-
Discussing the Phase 2b trial for demonstrating the effectiveness of combining bimagrumab – a drug designed to combat muscle loss – with a common GLP-1 receptor agonist (RA), semaglutide.
Ticker: LLY
Executed On: Jun 30, 2025 at 03:15 PM EDT
Upcoming & Overdue Catalysts (BIMAGRUMAB)
-
Don’t see a catalyst related to the keyword you care about? Create your own!
Occurred Catalysts (BIMAGRUMAB)
-
Novartis (NVS) Announces Plans for Phase 2 Trial Assessing MorphoSys Ag's (MPSYF) Bimagrumab in Obese Patients with Type 2 Diabetes
Tickers: NVS, MPSYF
Occurred on: Jan 12, 2017
Strategic Initiatives (BIMAGRUMAB)
-
Don’t see a strategic initiative related to the keyword you care about? Create your own!
